- Home
- SBFM vs MGIC Comparison
SBFM vs MGIC Comparison
Compare SBFM & MGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBFM | MGIC |
|---|---|---|
| Founded | 2006 | 1983 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 990.3M |
| IPO Year | N/A | 1991 |
Fundamental Metrics
Financial Performance| Metric | SBFM | MGIC |
|---|---|---|
| Price | $1.37 | $26.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 58.4K | 39.1K |
| Earning Date | 11-13-2025 | 11-18-2025 |
| Dividend Yield | N/A | ★ 2.22% |
| EPS Growth | N/A | ★ 16.15 |
| EPS | N/A | ★ 0.81 |
| Revenue | $37,323,742.00 | ★ $603,216,000.00 |
| Revenue This Year | $10.26 | $12.87 |
| Revenue Next Year | $32.63 | $6.23 |
| P/E Ratio | ★ N/A | $33.45 |
| Revenue Growth | ★ 13.24 | 12.65 |
| 52 Week Low | $1.16 | $11.36 |
| 52 Week High | $3.90 | $27.44 |
Technical Indicators
Market Signals| Indicator | SBFM | MGIC |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 59.11 |
| Support Level | $1.16 | $26.61 |
| Resistance Level | $1.40 | $27.31 |
| Average True Range (ATR) | 0.08 | 0.70 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 77.78 | 88.89 |
Price Performance
Historical ComparisonAbout SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.